Valuation: TELCON RF PHARMACEUTICAL. Inc.

Market Cap 11.75B 8.87M 7.92M 7.32M 6.63M 12.4M 842M 12.61M 88.04M 34.86M 441M 33.28M 32.57M 1.39B P/E 2024
-2.64x
P/E 2025 -3.84x
Enterprise Value 13.89B 10.49M 9.36M 8.65M 7.84M 14.67M 995M 14.91M 104M 41.21M 522M 39.35M 38.52M 1.64B EV / Sales 2024
3.07x
EV / Sales 2025 1.51x
Free-Float
83.87%
Yield 2024 *
-
Yield 2025 -
07-14 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 4.999999736 billion in funding from Telcon Holdings Co., Ltd. CI
07-05 TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 4.999999736 billion in funding from Telcon Holdings Co., Ltd. CI
07-02 KPM TECH Co., Ltd. announced that it expects to receive KRW 22.499999595 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
04-17 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 3 billion in funding from Nuon Co., Ltd. CI
04-16 KPM TECH Co., Ltd. announced that it has received KRW 7.9999997 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
04-06 TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 3 billion in funding from Nuon Co., Ltd. CI
04-06 KPM TECH Co., Ltd. announced that it expects to receive KRW 7.999999854 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
25-05-23 Telcon Rf Pharmaceutical To Conduct Capital Increase Of 28 Billion Won RE
25-04-21 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 12 billion in funding from Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd. CI
25-04-20 TELCON RF PHARMACEUTICAL. Inc. announced that it expects to receive KRW 12 billion in funding from Sangsangin Savings Bank, Sangsangin Plus Savings Bank Co.,Ltd. CI
25-03-17 TELCON RF PHARMACEUTICAL. Inc. Auditor Raises 'Going Concern' Doubt CI
24-12-22 ABION Inc. announced that it has received KRW 8.0011152 billion in funding from TELCON RF PHARMACEUTICAL. Inc. CI
24-12-11 TELCON RF PHARMACEUTICAL. Inc. announced that it has received KRW 2.5 billion in funding CI
1 day-1.65%
1 week-3.91%
Current month-3.69%
1 month-4.35%
3 months+1.46%
6 months-69.75%
Current year-77.21%
1 week 2,000
Extreme 2000
2,245
1 month 2,000
Extreme 2000
2,470
Current year 1,700
Extreme 1700
11,500
1 year 1,700
Extreme 1700
13,210
3 years 1,700
Extreme 1700
44,333.33
5 years 1,700
Extreme 1700
125,833.33
10 years 1,700
Extreme 1700
648,333.33
Manager TitleAgeSince
Chief Executive Officer 56 2017-10-31
Director of Finance/CFO 50 2019-03-27
Corporate Officer/Principal 54 2022-03-29
Director TitleAgeSince
Director/Board Member 50 2019-03-27
Director/Board Member 49 2019-03-27
Director/Board Member 56 2017-10-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/20/25 ExerciceCompany 1,111,280 4.8639%
8/20/25 ConversionCompany 1,111,280 4.8639%
7/30/25 FreeCompany 2,222,560 18.4828%
Change 5-day change 1-year change 3-year change Capi.($)
-1.65%-3.91%-79.65%-90.79% 8.87M
+1.53%-0.83%+50.79%+100.91% 420B
+0.76%-2.60%+12.06%+261.95% 217B
+1.96%+2.24%-27.36%+255.01% 145B
+3.82%-8.56%+24.01%+795.28% 108B
+0.84%+4.03%+9.76%+71.20% 79.74B
+0.48%-8.25%+321.73%+1,861.02% 68.5B
-0.56%+3.14%+17.28%+187.02% 56.65B
-0.83%-12.49%+38.17%+143.64% 46.7B
+4.19%+0.36%+1.47%-0.27% 46.41B
Average +1.05%-2.79%+36.83%+358.50% 118.83B
Weighted average by Cap. +1.45%-2.90%+40.56%+313.43%

Financials

2024 2025
Net sales 37.87B 28.58M 25.52M 23.58M 21.37M 39.98M 2.71B 40.64M 284M 112M 1.42B 107M 105M 4.48B 43.16B 32.58M 29.09M 26.88M 24.36M 45.57M 3.09B 46.32M 323M 128M 1.62B 122M 120M 5.11B
Net income -26.32B -19.87M -17.74M -16.39M -14.85M -27.79M -1.89B -28.25M -197M -78.09M -988M -74.56M -72.98M -3.12B -11.46B -8.65M -7.72M -7.13M -6.46M -12.09M -821M -12.29M -85.84M -33.99M -430M -32.45M -31.76M -1.36B
Net Debt 45.65B 34.46M 30.77M 28.43M 25.76M 48.2M 3.27B 49M 342M 135M 1.71B 129M 127M 5.4B 2.14B 1.62M 1.44M 1.33M 1.21M 2.26M 154M 2.3M 16.06M 6.36M 80.47M 6.07M 5.94M 254M
Projected Income Statement - Annual - TELCON RF PHARMACEUTICAL. Inc.
Logo TELCON RF PHARMACEUTICAL. Inc.
TELCON RF PHARMACEUTICAL. Inc., formerly TELCON.Inc, is a Korea-based company principally engaged in the manufacture and distribution of connectors and cable assemblies. The Company’s products mainly consist of radio frequency (RF) connectors, RF cables, couplers, dividers, arrestors, terminations, adapters, and other cable assemblies, which are used for wireless communication equipment.
Employees
126
Date Price Change Volume
26-10-23 ₩2,090.00 -1.65% 8,677
26-10-22 ₩2,125.00 -0.93% 5,052
26-10-21 ₩2,145.00 -2.05% 8,395
26-10-20 ₩2,190.00 0.00% 3,770
26-10-19 ₩2,190.00 +0.69% 19,930
  1. Stock Market
  2. Stocks
  3. A200230 Stock